| Reference | </br>1:Proton pump inhibitor ilaprazole suppresses cancer growth by targeting T-cell-originated protein kinase. Zheng M, Luan S, Gao S, Cheng L, Hao B, Li J, Chen Y, Hou X, Chen L, Li H.Oncotarget. 2017 Mar 27. doi: 10.18632/oncotarget.16609. [Epub ahead of print] PMID: 28388576 Free Article</br>2:Development of Solid-Phase Extraction and HPLC Method for Simultaneous Estimation of Ilaprazole and Glimepiride in Rat Plasma: Application to Pharmacokinetic Studies. Dewani AP, Tripathi AS, Shelke PG, Bakal RL, Mohale DS, Chandewar AV.J Chromatogr Sci. 2017 Mar 1;55(3):327-333. doi: 10.1093/chromsci/bmw189. PMID: 28069690 </br>3:Modeling the cost-effectiveness of ilaprazole versus omeprazole for the treatment of newly diagnosed duodenal ulcer patients in China. Xuan JW, Song RL, Xu GX, Lu WQ, Lu YJ, Liu Z.J Med Econ. 2016 Nov;19(11):1056-1060. Epub 2016 Jun 10. PMID: 27223846 </br>4:A Randomized, Double-blind, Active-Controlled, Multi-center Study of Ilaprazole in the Treatment of Reflux Esophagitis. Xue Y, Qin X, Zhou L, Lin S, Wang L, Hu H, Xia J.Clin Drug Investig. 2016 Dec;36(12):985-992. PMID: 27605258 </br>5:Ilaprazole for the treatment of gastro-esophageal reflux. Savarino E, Ottonello A, Martinucci I, Dulbecco P, Savarino V.Expert Opin Pharmacother. 2016 Oct;17(15):2107-13. doi: 10.1080/14656566.2016.1232389. Epub 2016 Sep 12. Review. PMID: 27598861 </br>6:Esophageal Acidification During Nocturnal Acid-breakthrough with Ilaprazole Versus Omeprazole in Gastroesophageal Reflux Disease. Karyampudi A, Ghoshal UC, Singh R, Verma A, Misra A, Saraswat VA.J Neurogastroenterol Motil. 2017 Apr 30;23(2):208-217. doi: 10.5056/jnm16087. PMID: 27585842 Free PMC Article</br>7:High Dose Ilaprazole/Amoxicillin as First-Line Regimen for Helicobacter pylori Infection in Korea. Kwack W, Lim Y, Lim C, Graham DY.Gastroenterol Res Pract. 2016;2016:1648047. doi: 10.1155/2016/1648047. Epub 2016 Jun 19. PMID: 27413365 Free PMC Article</br>8:Pharmacokinetics, Pharmacodynamics and Safety of Multiple-Infusion Ilaprazole in Healthy Chinese Subjects. Wang H, Lang L, Ou N, Shi R, Hu H, Hu P, Jiang J.Clin Drug Investig. 2016 Jun;36(6):463-70. doi: 10.1007/s40261-016-0390-2. PMID: 27067231 </br>9:Pharmacokinetics and pharmacodynamics of intravenous ilaprazole in healthy subjects after single ascending doses. Wang H, Ou N, Lang L, Shi R, Hu P, Jiang J.Xenobiotica. 2016 Dec;46(12):1133-1141. Epub 2016 Mar 21. PMID: 26998954 </br>10:Modeling The Cost-Effectiveness of Ilaprazole Vs. Omeprazole for The Treatment of Newly Diagnosed Duodenal Ulcer Patients In China. Lu YJ, Xu GX, Lu WQ, Liu Z, Rl S, Xuan J.Value Health. 2015 Nov;18(7):A625. doi: 10.1016/j.jval.2015.09.2200. Epub 2015 Oct 20. No abstract available. PMID: 26533511 Free Article
|
